Additionally, overexpression of Cyclin D1, a binding partner with CDK4/6, in neuroblasts and low Cyclin D1 expression in ganglioneuroma indicate an involvement of dysregulation of the G1 cell cycle checkpoint in neuroblastic tumor differentiation [6]. Here, CDK4 is linked to neoplasm.